Results

Total Results: over 10,000 records

Showing results for "treatment".

401. S123 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s123.pdf
     October 01, 2007 - If ESBC patients choose treatments based on Eq. (2), standard estimation of Brooks and Chrischilles … Combination therapies and the theoretical limits of evidence-based medicine. … Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European … therapy in operable breast cancer: EORTC trial 10801, breast concervation compared with mastectomy in … Factors predicting the use of breast-conserving therapy in stage I and II breast cancer.

402. Disposition of Comments for Technical Brief 28 MAT Models (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-use-disorder_disposition-comments.pdf
     December 06, 2016 - , but in those illnesses, we talk about pharmacologic treatments and non-pharmacologic treatments, … not medication-assisted treatments, because the professional community assumes that treatment relying … We don't refer to treatments for other chronic diseases as Medication Assisted Treatment. … enhancement therapy.... to read cognitive-behavioral therapy, motivational enhancement therapy, and … counseling and other non-pharmacologic therapies."

403. Ch 5-User-Guide-To-Ocer 130129 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ch_5-user-guide-to-ocer_130129.pdf
     January 01, 2012 - Alternative Treatments Comparison of a treatment with a clinically meaningful alternative treatment … analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics … Effect of highly active antiretroviral therapy on incident AIDS using calendar period as an instrumental … Hormone replacement therapy and cardiovascular health in the United States. Med Care. … Cancer risk in patients with rheumatoid arthritis treated with anti–tumor necrosis factor a therapies

404. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0251_05-20-2010.pdf
     January 01, 2010 - Date: 11-15-10 1 Results of Topic Selection Process & Next Steps  Prevention and treatment … of pressure ulcers Comparator(s): Various measures used to assess risk; various treatment regimens … of pressure ulcers with dressings and is particularly interested in treatment stratified by the stage … What are the benefits and harms of pressure ulcer treatment regimens including the evidence for treatment … Standard, adjunctive, and novel therapies for the prevention and treatment of pressure ulcers have proliferated

405. Kidney-Disease-Medicine Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
     January 01, 2012 - diabetes and hypertension.16 In efforts to reduce the risk of complications from these conditions, therapeutic … CKD Treatment Benefits and Harms • In RCTs of patients with CKD stages 1–3, several treatments reduced … with macroalbuminuria, ACEI or ARB treatment in combination with other therapy, and treatments other … • Patient-level meta-analyses of treatment RCTs to evaluate the effect of treatments relative to … Effectiveness of statin therapy in adults with coronary heart disease.

406. Service Models | The Academy
     integrationacademy.ahrq.gov/products/playbooks/opioid-use-disorder/implement-mat-for-oud/service-models
     January 01, 2019 - For example, the West Virginia University Comprehensive Opioid Addiction Treatment (COAT) model uses … include: Performing the initial assessment, Delivering patient education, Making referrals to behavioral therapy … Patients are then transferred to primary care for the maintenance phase of treatment. … Documentation & Charge Capture Process: Medication-Assisted Treatment. … Principles of Substance Use Treatment Delivering Effective, Low Barrier Treatment

407. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0645-151012.pdf
     August 05, 2015 - Also, understanding modifiers of treatment and treatment pathways can help to optimize choices for patients … Decreased medication side effects; decreased unintended consequences/harms associated with therapies … What are modifiers of treatment and treatment pathways that can help to optimize choices for patients … , including pharmacologic, psychosocial/behavioral (e.g., cognitive behavioral therapy), and complementary … An updated synthesis of treatment options can help to inform clinical decision-making.

408. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
     September 13, 2011 - may be extended up to 48 weeks for patients with HCV genotype 1.5,6 The effects of antiviral therapies … may change with the introduction of the new drug class.13,14 Adherence to treatments has been shown … treatment outcomes specifically in HCV antiviral therapy or whether treatment adherence interventions … training), increasing the convenience of medication use (e.g., simplifying drug dosing, tailoring the treatments … • Treatment regimens: prescribed antiviral therapy.

409. Mental-Illness-Adults-Prisons Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-adults-prisons_executive.pdf
     August 01, 2013 - Four trials tested the efficacy of pharmacologic therapies. … Investigators compared cognitive therapy with other psychological treatment in three trials. … Evidence was insufficient that any of the other treatments assessed (other pharmacologic therapies, … cognitive therapy to be more effective than other standard psychological treatment. … Direct Insufficient Modified therapeutic community vs.

410. The Effectiveness of Indoor Allergen Reduction and the Role of Bronchial Thermoplasty in the Management of Asthma | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/asthma-nonpharmacologic-treatment/research-protocol

411. Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/asthma-pharmacologic-treatment/research-2017

412. Systematic Review of Intermittent Inhaled Corticosteroids and of Long-acting Muscarinic Antagonists for Asthma | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/asthma-pharmacologic-treatment/research-protocol

413. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis_hi_impact.pdf
     January 01, 2014 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … Mesenchymal stem cell therapy for treatment of osteoarthritis 3. … = 0.043 and p = 0.010 respectively). 54 Autologous PRP is not currently considered a drug or a therapeutic … Gout therapeutics: new drugs for an old disease. Lancet 2011 Jan 8;377(9760):165-77.

414. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd_research-protocol.pdf
     August 10, 2010 - including alternative treatments • Any pharmaceutical treatment • Any psychosocial or behavioral … or parent training treatment or combination treatment • Not including alternative treatments … • Any pharmaceutical treatment • Not including alternative treatments Comparator/ Design … or combination treatment compared against placebo or any other of the above treatments • Not case … or combination treatment compared against placebo or any other of the above treatments • Not case

415. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0094_04-09-2009.pdf
     January 01, 2009 - for autism including occupational, speech, and physical therapies and drug effectiveness. … Areas of interest from the second nominator include combined treatments, effectiveness of early interventions … Understanding the combined effectiveness of medical and behavioral treatments a. … treatment plus a pharmacological treatment versus pharmacological treatment alone in reducing depressive … clear that there is a real need for synthesized research that evaluates the evidence base for various treatments

416. Utilizing Health Information Technology to Improve Health Care Quality - Final Report (pdf file)
     digital.ahrq.gov/sites/default/files/docs/publication/r18hs018665-storch-final-report-2015.pdf
     January 01, 2015 - the needs of each client and, depending on the design, could lack important therapeutic components. … A randomized controlled trial of computer-assisted cognitive-behavioral therapy versus treatment as … A randomized controlled trial of computer-assisted cognitive-behavioral therapy versus treatment as … A randomized controlled trial of computer-assisted cognitive-behavioral therapy versus treatment as … CCBT=Computer-assisted cognitive-behavioral therapy; TAU=treatment as usual; PARS=Pediatric Anxiety

417. Hi Les, (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/rtc-design-principles_research.pdf
     January 01, 2009 - Test-treatment pathway Treatment effects. … more sensitive test, just as they are needed to assess the efficacy of new treatments. … Results of conservative surgery and radiation therapy for multiple synchronous cancers of one breast … Standard for breast conservation therapy in the management of invasive breast carcinoma. … The role of before-after studies of therapeutic impact in the evaluation of diagnostic technologies

418. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_executive.pdf
     September 01, 2011 - as therapies for patients with TRD: electroconvulsive therapy (ECT), repetitive transcranial magnetic … Comparisons of these nonpharmacologic therapies are our main interest. … How do the efficacy, effectiveness, or harms of treatment with nonpharmacologic treatments for TRD differ … Direct comparisons of treatment strategies, holding consistent any coexisting or concomitant therapies … When ongoing treatment is uncontrolled and reflects a variety of treatments—e.g., some patients continue

419. An analytical framework for quantifying components of variability in prescriber decisions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/instrumental-variable-methods_research.pdf
     April 01, 2010 - Example 2: The Hospital Formulary Suppose that a new thrombolytic therapy is introduced for the treatment … The new medication is thought to be more effective than existing therapies, but it is expensive and … Thus, providers who preferentially use one treatment must not also preferentially use other treatments … For example, in effectiveness studies, underuse of a therapy results in the IV up-weighting the treatment … Estimating probit models with self-selected treatments. Stat Med 2006;25:389-413. 63.

420. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
     September 01, 2011 - Therefore it is good that this report includes trials comparing to controls, sham therapies and pharmacological … The study compares baseline and post-treatment outcomes after electroconvulsive therapy. … Their call for action, such as more uniformity in diagnosis and in therapeutic protocols, is well thought … patient receiving long-term dynamic therapy was better off than 96% of patients receiving other treatments … Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments